These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 4913828

  • 21. Asparaginase: molecular and enzymic requirements for use as an antileukaemia agent.
    Wade HE.
    J Gen Microbiol; 1971 Mar; 65(3):x-xi. PubMed ID: 4997395
    [No Abstract] [Full Text] [Related]

  • 22. [Biological properties of L-asparaginase preparations from E. coli in cell cultures].
    Kondrat'eva NA, Dobrynin IaV, Merkulov MF.
    Antibiotiki; 1978 Jan; 23(1):43-5. PubMed ID: 341799
    [Abstract] [Full Text] [Related]

  • 23. [The effect of L-asparaginase on fibrinogen and fibrin clot. The tumor-growth inhibiting action of L-asparaginase].
    Benkö SA, Laki K.
    Arch Geschwulstforsch; 1969 Jan; 34(2):102-15. PubMed ID: 4920115
    [No Abstract] [Full Text] [Related]

  • 24. Biochemical and pharmacological studies with asparaginase in man.
    Ohnuma T, Holland JF, Freeman A, Sinks LF.
    Cancer Res; 1970 Sep; 30(9):2297-305. PubMed ID: 4920133
    [No Abstract] [Full Text] [Related]

  • 25. Principal biochemical characteristics of the EC-2 L-asparaginase from Escherichia coli AT.
    Smékal F.
    Neoplasma; 1969 Sep; 16(4):469-70. PubMed ID: 4899032
    [No Abstract] [Full Text] [Related]

  • 26. Glycine inhibition of asparaginase.
    Ryan WL, Sornson HC.
    Science; 1970 Mar 13; 167(3924):1512-3. PubMed ID: 4906004
    [Abstract] [Full Text] [Related]

  • 27. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL, Wu MS, Chen Z.
    Acta Pharmacol Sin; 2002 Oct 13; 23(10):946-51. PubMed ID: 12370101
    [Abstract] [Full Text] [Related]

  • 28. Enhancement of asparaginase-induced regression of the 6C3HED lymphosarcoma by protein-free diet.
    Ryan WL, Sornson HC.
    Cancer Res; 1973 May 13; 33(5):1062-4. PubMed ID: 4574058
    [No Abstract] [Full Text] [Related]

  • 29. Biochemical method of cancer control. L-asparaginase in cancer chemotherapy. A review.
    Jayaram HN, Sirsi M.
    Indian J Cancer; 1970 Mar 13; 7(1):71-7. PubMed ID: 4992298
    [No Abstract] [Full Text] [Related]

  • 30. Increased antitumor activity of Escherichia coli. L-asparaginase by modification with monomethoxypolyethylene glycol.
    Kamisaki Y, Wada H, Yagura T, Nishimura H, Matsushima A, Inada Y.
    Gan; 1982 Jun 13; 73(3):470-4. PubMed ID: 6751921
    [Abstract] [Full Text] [Related]

  • 31. Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators.
    Holland JF, Ohnuma T.
    Cancer Treat Rep; 1981 Jun 13; 65 Suppl 4():123-30. PubMed ID: 7049376
    [Abstract] [Full Text] [Related]

  • 32. L-asparaginase: a review.
    Wriston JC, Yellin TO.
    Adv Enzymol Relat Areas Mol Biol; 1973 Jun 13; 39():185-248. PubMed ID: 4583638
    [No Abstract] [Full Text] [Related]

  • 33. [Bacterial L-asparaginase and glutamin(asparagin)ase: some properties, structure and anti-tumor activity].
    Sokolov NN, Zanin VA, Aleksandrova SS.
    Vopr Med Khim; 2000 Jun 13; 46(6):531-48. PubMed ID: 11234278
    [Abstract] [Full Text] [Related]

  • 34. An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.
    Nath CE, Dallapozza L, Eslick AE, Misra A, Carr D, Earl JW.
    Biomed Chromatogr; 2009 Feb 13; 23(2):152-9. PubMed ID: 18823071
    [Abstract] [Full Text] [Related]

  • 35. Regeneration, tumor, dietary, and L-asparaginase effects on asparagine biosynthesis in rat liver.
    Patterson MK, Orr GR.
    Cancer Res; 1969 Jun 13; 29(6):1179-83. PubMed ID: 4894450
    [No Abstract] [Full Text] [Related]

  • 36. The effects of L-asparaginase on the amino acid incorporation of mouse lymphoid tumors.
    Mashburn LT, Gordon CS.
    Cancer Res; 1968 May 13; 28(5):961-7. PubMed ID: 5652310
    [No Abstract] [Full Text] [Related]

  • 37. L-asparaginase and L-asparagine metabolism.
    Cooney DA, Handschumacher RE.
    Annu Rev Pharmacol; 1970 May 13; 10():421-40. PubMed ID: 4911021
    [No Abstract] [Full Text] [Related]

  • 38. Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors.
    Broome JD.
    Br J Cancer; 1968 Sep 13; 22(3):595-602. PubMed ID: 4878639
    [No Abstract] [Full Text] [Related]

  • 39. Studies on the mechanism of tumor inhibition by L-asparaginase. Effects of the enzyme on asparagine levels in the blood, normal tissues, and 6C3HED lymphomas of mice: differences in asparagine formation and utilization in asparaginase-sensitive and -resistant lymphoma cells.
    Broome JD.
    J Exp Med; 1968 Jun 01; 127(6):1055-72. PubMed ID: 4871211
    [Abstract] [Full Text] [Related]

  • 40. [Antileukemic action of L-asparaginase].
    Yamada K, Hirano M, Kakizawa H, Morita A, Uetani T.
    Saishin Igaku; 1970 May 01; 25(5):1064-74. PubMed ID: 5421876
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.